227 related articles for article (PubMed ID: 24524743)
21. Light-chain cardiac amyloidosis.
Mankad AK; Sesay I; Shah KB
Curr Probl Cancer; 2017; 41(2):144-156. PubMed ID: 28117074
[TBL] [Abstract][Full Text] [Related]
22. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.
Boynton SJ; Geske JB; Dispenzieri A; Syed IS; Hanson TJ; Grogan M; Araoz PA
JACC Cardiovasc Imaging; 2016 Jun; 9(6):680-6. PubMed ID: 27209101
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive risk stratification of patients with transthyretin amyloidosis.
Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
[TBL] [Abstract][Full Text] [Related]
24. Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center.
López-Sainz Á; Hernandez-Hernandez A; Gonzalez-Lopez E; Domínguez F; Restrepo-Cordoba MA; Cobo-Marcos M; Gómez-Bueno M; Hernandez-Perez FJ; Oteo JF; Mirelis JG; Cavero MA; Moñivas V; Mingo Santos S; de Haro-Del Moral FJ; Krsnik I; Salas C; Bornstein B; Briceño A; López JA; Vázquez J; Alonso-Pulpón L; Segovia J; Garcia-Pavia P
Rev Esp Cardiol (Engl Ed); 2021 Feb; 74(2):149-158. PubMed ID: 32317158
[TBL] [Abstract][Full Text] [Related]
25. Response: Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor.
Henein MY; Lindqvist P
Amyloid; 2018 Jun; 25(2):136. PubMed ID: 29529882
[No Abstract] [Full Text] [Related]
26. Recent advances in the noninvasive strategies of cardiac amyloidosis.
Zhao L; Fang Q
Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
[TBL] [Abstract][Full Text] [Related]
27. Clinical and echocardiographic characteristics for differentiating between transthyretin-related and light-chain cardiac amyloidoses.
Mori M; An Y; Katayama O; Kitagawa T; Sasaki Y; Onaka T; Yonezawa A; Murata K; Yokota T; Ando K; Imada K
Ann Hematol; 2015 Nov; 94(11):1885-90. PubMed ID: 26251157
[TBL] [Abstract][Full Text] [Related]
28. Cardiac amyloidosis: a practical approach to diagnosis and management.
Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
[TBL] [Abstract][Full Text] [Related]
29. [Cardiac amyloidosis].
Hoyer C; Angermann CE; Knop S; Ertl G; Störk S
Med Klin (Munich); 2008 Mar; 103(3):153-60. PubMed ID: 18344065
[TBL] [Abstract][Full Text] [Related]
30. Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shock.
Damy T; Plante-Bordeneuve V; Dogan A
Arch Cardiovasc Dis; 2014 Dec; 107(12):706-8. PubMed ID: 24070596
[No Abstract] [Full Text] [Related]
31. Current role of imaging techniques in cardiac amyloidosis.
Pudis M; Bastarrika Alemañ G
Med Clin (Barc); 2023 Feb; 160(3):121-128. PubMed ID: 36543710
[TBL] [Abstract][Full Text] [Related]
32. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
[TBL] [Abstract][Full Text] [Related]
33. Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122).
Nichols WC; Liepnieks JJ; Snyder EL; Benson MD
J Lab Clin Med; 1991 Mar; 117(3):175-80. PubMed ID: 2002274
[TBL] [Abstract][Full Text] [Related]
34. Clinical features and survival in senile systemic amyloidosis: comparison to familial transthyretin cardiomyopathy.
Connors LH; Doros G; Sam F; Badiee A; Seldin DC; Skinner M
Amyloid; 2011 Jun; 18 Suppl 1(Suppl 1):157-9. PubMed ID: 21838471
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.
Dahlem K; Michels G; Kobe C; Bunck AC; Ten Freyhaus H; Pfister R
Clin Res Cardiol; 2017 Jun; 106(6):471-473. PubMed ID: 28303323
[No Abstract] [Full Text] [Related]
36. Identification of Wild-Type Transthyretin Cardiac Amyloidosis by Quantifying Myocardial Extracellular Volume Using Cardiac Computed Tomography in Atrial Arrhythmias.
Oda S; Kidoh M; Takashio S; Nishi M; Kanazawa H; Nagayama Y; Nakaura T; Tsujita K; Ikeda O
Circ Cardiovasc Imaging; 2020 Jun; 13(6):e010261. PubMed ID: 32438825
[No Abstract] [Full Text] [Related]
37. Suspecting and diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) in India: An Indian expert consensus.
Chander Mohan J; Dalal J; Chopra VK; Narasimhan C; Kerkar P; Oomman A; Ray Fcsi S; Sharma AR; Dougall P; Simon S; Verma Drm A; Radhakrishnan V
Indian Heart J; 2022; 74(6):441-449. PubMed ID: 36410415
[TBL] [Abstract][Full Text] [Related]
38. Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis.
Wixner J; Pilebro B; Lundgren HE; Olsson M; Anan I
Amyloid; 2017 Mar; 24(sup1):78-79. PubMed ID: 28042702
[No Abstract] [Full Text] [Related]
39. Direct tissue evaluation via immunofluorescence: in the diagnosis of hereditary transthyretin cardiac amyloidosis.
Fradley MG; Thakuria JV; Collins AB; Moore SA; Stone JR
Tex Heart Inst J; 2012; 39(1):71-5. PubMed ID: 22412233
[TBL] [Abstract][Full Text] [Related]
40. Cardiac Amyloidosis: Diagnosis and Treatment Strategies.
Tuzovic M; Yang EH; Baas AS; Depasquale EC; Deng MC; Cruz D; Vorobiof G
Curr Oncol Rep; 2017 Jul; 19(7):46. PubMed ID: 28528458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
